127 related articles for article (PubMed ID: 37305933)
1. [Clinical and biological features and prognosis of patients with leukemic non-nodal mantle cell lymphoma].
Chen JW; Wang Y; Yan YT; Xiong WJ; Wang TY; Liu W; Zou DH; Qiu LG; Yi SH
Zhonghua Yi Xue Za Zhi; 2023 Jun; 103(23):1746-1752. PubMed ID: 37305933
[No Abstract] [Full Text] [Related]
2. A gene signature that distinguishes conventional and leukemic nonnodal mantle cell lymphoma helps predict outcome.
Clot G; Jares P; Giné E; Navarro A; Royo C; Pinyol M; Martín-Garcia D; Demajo S; Espinet B; Salar A; Ferrer A; Muntañola A; Aymerich M; Rauert-Wunderlich H; Jaffe ES; Connors JM; Gascoyne RD; Delabie J; López-Guillermo A; Ott G; Wright GW; Staudt LM; Rosenwald A; Scott DW; Rimsza LM; Beà S; Campo E
Blood; 2018 Jul; 132(4):413-422. PubMed ID: 29769262
[TBL] [Abstract][Full Text] [Related]
3. Highly sensitive and specific
Federmann B; Frauenfeld L; Pertsch H; Borgmann V; Steinhilber J; Bonzheim I; Fend F; Quintanilla-Martinez L
Haematologica; 2020 Mar; 105(3):754-764. PubMed ID: 31296581
[TBL] [Abstract][Full Text] [Related]
4. Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.
Isaac KM; Portell CA; Williams ME
Curr Oncol Rep; 2021 Jul; 23(9):102. PubMed ID: 34269910
[TBL] [Abstract][Full Text] [Related]
5. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
Nadeu F; Martin-Garcia D; Clot G; Díaz-Navarro A; Duran-Ferrer M; Navarro A; Vilarrasa-Blasi R; Kulis M; Royo R; Gutiérrez-Abril J; Valdés-Mas R; López C; Chapaprieta V; Puiggros M; Castellano G; Costa D; Aymerich M; Jares P; Espinet B; Muntañola A; Ribera-Cortada I; Siebert R; Colomer D; Torrents D; Gine E; López-Guillermo A; Küppers R; Martin-Subero JI; Puente XS; Beà S; Campo E
Blood; 2020 Sep; 136(12):1419-1432. PubMed ID: 32584970
[TBL] [Abstract][Full Text] [Related]
6. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.
Hu Z; Sun Y; Schlette EJ; Tang G; Li S; Xu J; Yin CC; Young KH; Patel KP; Miranda RN; Goswami M; Wang M; Jorgensen JL; Medeiros LJ; Wang SA
Mod Pathol; 2018 Feb; 31(2):327-336. PubMed ID: 28984300
[TBL] [Abstract][Full Text] [Related]
7. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract][Full Text] [Related]
8. An overlapping case of in situ mantle cell neoplasia and leukemic non-nodal mantle cell lymphoma.
Matsuoka R; Sakamoto N; Sakata-Yanagimoto M; Chiba S; Noguchi M; Nakamura N
J Clin Exp Hematop; 2020 Dec; 60(4):169-173. PubMed ID: 33028761
[TBL] [Abstract][Full Text] [Related]
9. Genomic and gene expression profiling defines indolent forms of mantle cell lymphoma.
Fernàndez V; Salamero O; Espinet B; Solé F; Royo C; Navarro A; Camacho F; Beà S; Hartmann E; Amador V; Hernández L; Agostinelli C; Sargent RL; Rozman M; Aymerich M; Colomer D; Villamor N; Swerdlow SH; Pileri SA; Bosch F; Piris MA; Montserrat E; Ott G; Rosenwald A; López-Guillermo A; Jares P; Serrano S; Campo E
Cancer Res; 2010 Feb; 70(4):1408-18. PubMed ID: 20124476
[TBL] [Abstract][Full Text] [Related]
10. Leukemic non-nodal mantle cell lymphomas have a distinct phenotype and are associated with deletion of PARP1 and 13q14.
Gallo M; Cacheux V; Vincent L; Bret C; Tempier A; Guittard C; Macé A; Leventoux N; Costes V; Szablewski V
Virchows Arch; 2016 Dec; 469(6):697-706. PubMed ID: 27605053
[TBL] [Abstract][Full Text] [Related]
11. Role of SOX11 and Genetic Events Cooperating with Cyclin D1 in Mantle Cell Lymphoma.
Beà S; Amador V
Curr Oncol Rep; 2017 Jun; 19(6):43. PubMed ID: 28466437
[TBL] [Abstract][Full Text] [Related]
12. Indolent mantle cell leukemia: a clinicopathological variant characterized by isolated lymphocytosis, interstitial bone marrow involvement, kappa light chain restriction, and good prognosis.
Ondrejka SL; Lai R; Smith SD; Hsi ED
Haematologica; 2011 Aug; 96(8):1121-7. PubMed ID: 21508124
[TBL] [Abstract][Full Text] [Related]
13. Smoldering mantle cell lymphoma.
Ye H; Desai A; Zeng D; Nomie K; Romaguera J; Ahmed M; Wang ML
J Exp Clin Cancer Res; 2017 Dec; 36(1):185. PubMed ID: 29246179
[TBL] [Abstract][Full Text] [Related]
14. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
15. Biological and Clinical Determinants Shaping Heterogeneity in Mantle Cell Lymphoma.
López C; Silkenstedt E; Dreyling M; Beà S
Blood Adv; 2024 May; ():. PubMed ID: 38748869
[TBL] [Abstract][Full Text] [Related]
16. Outcome prediction of advanced mantle cell lymphoma by international prognostic index versus different mantle cell lymphoma indexes: one institution study.
Todorovic M; Balint B; Andjelic B; Stanisavljevic D; Kurtovic NK; Radisavljevic Z; Mihaljevic B
Med Oncol; 2012 Sep; 29(3):2212-9. PubMed ID: 22170090
[TBL] [Abstract][Full Text] [Related]
17. Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.
Qiu L; Xu J; Tang G; Wang SA; Lin P; Ok CY; Garces S; Yin CC; Khanlari M; Vega F; Medeiros LJ; Li S
Hum Pathol; 2022 Jan; 119():59-68. PubMed ID: 34767860
[TBL] [Abstract][Full Text] [Related]
18. Mantle Cell Lymphoma of Mucosa-Associated Lymphoid Tissue: A European Mantle Cell Lymphoma Network Study.
Morello L; Rattotti S; Giordano L; Jerkeman M; van Meerten T; Krawczyk K; Moita F; Marino D; Ferrero S; Szymczyk M; Aurer I; El-Galaly TC; Di Rocco A; Visco C; Carli G; Defrancesco I; Carlo-Stella C; Dreyling M; Santoro A; Arcaini L
Hemasphere; 2020 Feb; 4(1):e302. PubMed ID: 32072136
[TBL] [Abstract][Full Text] [Related]
19. Identification of miR-15b as a transformation-related factor in mantle cell lymphoma.
Arakawa F; Kimura Y; Yoshida N; Miyoshi H; Doi A; Yasuda K; Nakajima K; Kiyasu J; Niino D; Sugita Y; Tashiro K; Kuhara S; Seto M; Ohshima K
Int J Oncol; 2016 Feb; 48(2):485-92. PubMed ID: 26676972
[TBL] [Abstract][Full Text] [Related]
20. CD5-negative mantle cell lymphoma: clinicopathologic features of an indolent variant that confers a survival advantage.
Soleimani A; Navarro A; Liu D; Herman SEM; Chuang SS; Slavutsky I; Narbaitz M; Safah H; Schmieg J; Lefante J; Roschewski M; Wilson WH; Wiestner A; Saba NS
Leuk Lymphoma; 2022 Apr; 63(4):911-917. PubMed ID: 34781807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]